Asthma and chronic rhinosinusitis (CRS)—sinus inflammation that lasts for at least three months—are serious and costly diseases, and both are on the rise. According to the American Academy of Allergy, Asthma and Immunology, CRS affects up to 16 percent of the U.S. adult population and eats up a staggering 5 percent of the country’s healthcare budget each year. Asthma,… Read more
According to the National Institutes for Health, asthma is a chronic lung disease affecting more than 300 million people worldwide—25 million in the U.S. alone, including 7 million children. Because it inflames and narrows the airways, the disease significantly affects quality of life, causing recurring periods of wheezing, chest tightness, shortness of breath and coughing.
The incidence of asthma… Read more
According to the Centers for Disease Control and Prevention, more than 16 percent of adults in the United States have been diagnosed with chronic rhinosinusitis, or CRS—commonly defined as a sinus infection and inflammation that lasts more than 12 weeks. Not only do CRS patients report a significantly worse quality of life than those with asthma,… Read more